The pooled analysis revealed a 59% reduction in arrhythmia incidence in the ACEIs group compared to the control, although this difference did not reach statistical significance (OR 0.41 [95% CI 0.05, 3.50], P =.42, I2=63%) ( Figure 6 ).
← all excerpts
Angiotensin converting enzyme inhibitors (ACEIs) for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials.
1
0.4200
0.4200